References
Decristoforo C, Mather SJ, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med 2000; 27:1318-1325.
Becker W, Schrell U, Buchfelder M, Hensen J, Wendler J, Gramatzki M, Wolf F. Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy. Nuklearmedizin 1995; 34:100-103.
Moncayo R, Baldissera I, Decristoforo C, Kendler D, Donnemiller E. Evaluation of immunological mechanisms mediating thyroidassociated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide. Thyroid 1997; 7:21-29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gabriel, M., Decristoforo, C. & Moncayo, R. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in Graves’ disease. Eur J Nucl Med 29, 1267 (2002). https://doi.org/10.1007/s00259-002-0927-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-002-0927-x